Gene: SCCPDH
Official Full Name: saccharopine dehydrogenase (putative)provided by HGNC
Gene Summary: Predicted to enable oxidoreductase activity. Predicted to be involved in glycolipid biosynthetic process. Located in lipid droplet and midbody. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23061 | SCCPDH Knockout cell line (HeLa) | Human | SCCPDH | 1:3~1:6 | Negative | Online Inquiry |
KO23062 | SCCPDH Knockout cell line (HEK293) | Human | SCCPDH | 1:3~1:6 | Negative | Online Inquiry |
KO23063 | SCCPDH Knockout cell line (A549) | Human | SCCPDH | 1:3~1:4 | Negative | Online Inquiry |
SCCPDH Gene Knockout Cell Lines are advanced, genetically engineered cell lines specifically designed to facilitate the study of the SCCPDH gene function and its associated biochemical pathways. By providing a model system where the SCCPDH gene is completely disrupted or "knocked out," these cell lines enable researchers to explore the gene's role in metabolic processes, particularly in relation to glycolysis and lipid metabolism.
The primary mechanism of action of these cell lines hinges on the CRISPR/Cas9 gene-editing technology, which offers precise disruption of the SCCPDH gene. Upon knockout, researchers can analyze the resulting phenotype, including alterations in metabolic pathways, cellular growth, and viability. This deep dive into gene function not only enhances our understanding of metabolic regulation but also uncovers potential therapeutic avenues for conditions linked to SCCPDH dysregulation.
The scientific importance of SCCPDH Gene Knockout Cell Lines extends beyond basic research; these models are invaluable in drug discovery and development, particularly in identifying novel therapeutic targets for metabolic diseases, cancer, and other disorders where SCCPDH plays a crucial role. Their application in high-throughput screening protocols significantly accelerates the pace of research.
One of the key advantages of using our SCCPDH Gene Knockout Cell Lines over alternative models is their superior specificity and reproducibility, paired with the convenience of readily available, curated datasets that accompany each cell line. Researchers benefit from detailed characterization and batch-to-batch consistency, reducing variability and increasing confidence in experimental results.
For researchers and clinicians alike, SCCPDH Gene Knockout Cell Lines represent a powerful tool to drive innovative discoveries in metabolic research and therapeutic development. With a commitment to excellence in biotechnological solutions, our company provides not only high-quality products but also unmatched expertise and support, ensuring that every research endeavor is built on a solid foundation of scientific rigor and reliability.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.